Merck & Co Inc MRK:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 4:28 PM EDT

130.96

-0.24 (-0.18%)

Volume

361,869

131.20

+0.48 (+0.37%)

Volume

7,390,911

52 week range

99.14 - 133.10

Open130.13
Day High131.91
Day Low130.13
Prev Close130.72
52 Week High133.10
52 Week High Date03/27/24
52 Week Low99.14
52 Week Low Date10/19/23

Key Stats

Market Cap332.333B
Shares Out2.53B
10 Day Average Volume7.51M
Dividend3.08
Dividend Yield2.35%
Beta0.40
YTD % Change20.34

KEY STATS

Open130.13
Day High131.91
Day Low130.13
Prev Close130.72
52 Week High133.10
52 Week High Date03/27/24
52 Week Low99.14
52 Week Low Date10/19/23
Market Cap332.333B
Shares Out2.53B
10 Day Average Volume7.51M
Dividend3.08
Dividend Yield2.35%
Beta0.40
YTD % Change20.34

RATIOS/PROFITABILITY

EPS (TTM)0.89
P/E (TTM)147.07
Fwd P/E (NTM)15.38
EBITDA (TTM)11.001B
ROE (TTM)0.87%
Revenue (TTM)61.402B
Gross Margin (TTM)75.61%
Net Margin (TTM)3.78%
Debt To Equity (MRQ)93.28%

EVENTS

Earnings Date07/30/2024(est)
Ex Div Date03/14/2024
Div Amount0.77
Split Date-
Split Factor-

Latest On Merck & Co Inc

Stocks making the biggest moves midday: Meta, Caterpillar, Microsoft and moreApril 25, 2024CNBC.com
Thursday's rapid fire: Caterpillar, Dow, Chipotle, Merck and ServiceNowApril 25, 2024CNBC.com
Jim Cramer's thoughts on Caterpillar, Dow, Chipotle, Merck and ServiceNowApril 25, 2024CNBC.com
Stocks making biggest moves premarket: Meta, Merck, Southwest and moreApril 25, 2024CNBC.com
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine salesApril 25, 2024CNBC.com

Content From Our Affiliates

Merck & Company: A Strong Buy on Robust Performance and Future Growth Prospects11 Hours AgoTipRanks
Merck & Co. Outperforms with Strong Keytruda Sales and Raised Guidance: A Buy Rating Affirmed11 Hours AgoTipRanks
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Globus Medical (GMED) and Merck & Company (MRK)12 Hours AgoTipRanks
Merck & Company (MRK) Gets a Buy from Barclays14 Hours AgoTipRanks
Merck price target raised to $143 from $142 at TruistApril 25, 2024TipRanks

Profile

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical...

Robert Davis

Chairman of the Board, President, Chief Executive Officer

Caroline Litchfield

Chief Financial Officer, Executive Vice President

Sanat Chattopadhyay

Executive Vice President and President - Merck Manufacturing Division

Dean Li M.D., Ph.D.

Executive Vice President, President - Merck Research Laboratories

Cristal Downing

Executive Vice President, Chief Communications and Public Affairs Officer

Address

2000 Galloping Hill Road

Kenilworth, NJ

07033

United States

https://www.merck.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
ABBV AbbVie Inc	159.62	-7.67	-4.58%
JNJ Johnson & Johnson	146.14	-0.68	-0.46%
AZN AstraZeneca PLC	75.17	+0.14	+0.19%
RHHBY Roche Holding AG	30.25	+0.23	+0.77%
NVS Novartis AG	97.44	-1.62	-1.64%